How to ensure rare cancers get the attention they deserve
Rare cancers, when grouped together, make-up roughly one-quarter of all EU cancer cases. How can we improve patient care for this often overlooked group?
Chief Executive Officer of the European Organisation for Research and Treatment of Cancer (EORTC). Based in Brussels, the EORTC is an independent, international, academic clinical research organisation, bringing together European clinical investigators from all disciplines across all tumour types to conduct research that improves quality of life and survival of cancer patients.